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Abstract
Background: Brazilian records on glycemic control in patients with type 1 diabetes show treatment efficacy. Poor
patient adherence to therapeutic proposals influences these results and can be associated with social, psychological, and
economic aspects, besides others factors. The aim of this study was to evaluate the efficacy of psychological, telecare,
and educational interventions to improve treatment compliance among patients with type 1 diabetes. Compliance was
assessed indirectly using reduction of glycated hemoglobin (HbA1c) as the principal outcome measure.
Methods: Systematic review and meta-analyses of randomized controlled clinical trials (RCTs) were performed using
Medline, Embase, Cochrane and Scopus databases up to April 2015. The following medical subject headings were used:
Diabetes Mellitus, Type 1, Patient Compliance or Adherence, Hemoglobin A, glycated, and Randomized Controlled Trial.
The principal outcome was change in HbA1c between baseline and follow-up. Where appropriate, trials were combined
in meta-analysis using fixed effects models.
Results: From 191 articles initially identified, 57 were full text reviewed, and 19 articles met the inclusion
criteria providing data from 1782 patients (49.4 % males, age 18 years). The RCTs (2 to 24 months in
duration) were divided into four groups according to type of intervention: psychology (seven studies; 818
patients), telecare (six studies; 494 patients); education (five studies; 349 patients), and psychoeducation (one
study; 153 patients). All studies reported some type of adherence measurement of the interventions. Decrease
in HbA1c was observed after psychology (MD −0.310; 95 % CI, −0.599 to −0.0210, P = 0.035) but not after
telecare (MD −0.124 %; 95 % CI, −0.268, 0.020; P = 0.090) or educational (MD −0.001; 95 % CI, −0.202, 0.200;
P = 0.990) interventions.
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Conclusion: Psychological approaches to improve adherence to diabetes care treatment modestly reduced
HbA1c in patients with type 1 diabetes; telecare and education interventions did not change glycemic
control. However, the limited number of studies included as well as their methodological quality should be
taken into account.
Keywords: Adherence, Non-pharmacological interventions, Type 1 diabetes, Systematic review, Meta-analyses
Background
A seminal study published in recent decades clearly
demonstrated that intensive glycemic treatment promot-
ing lower glycated hemoglobin (HbA1c) values, as com-
pared to standard care, can prevent or postpone chronic
diabetic complications [1]. Furthermore, follow-up of
these patients after the end-of-studies demonstrated that
past strict glycemic control was associated with a low
prevalence of complications years later. Patients inten-
sively treated early in the course of type 1 diabetes less
frequently developed impaired glomerular filtration rate
[2], increased urinary albumin excretion [2, 3], and also
had a lower risk of cardiovascular disease [4] than those
treated with conventional diabetes therapy. Reduction in
the risk of cardiovascular, renal, and ocular disease by
strict glycemic control was recently reinforced in a sys-
tematic review in these patients [5].
HbA1c measurement has been widely used to evaluate
glycemic control in patients with diabetes. It reflects the
average glycemia over several months [6] and should be
measured every 3 months. Whenever possible HbA1c tar-
gets should be maintained as close as possible to the non-
diabetic levels (<6.5 %) but goals must be individualized by
age and by the presence of chronic diabetic complications
[7]. Diabetes management requires adherence to a complex
daily therapeutic regimen in order to reduce HbA1c levels.
Patients have to be able to adhere to many procedures
such as self-blood glucose monitoring, diet plan, insulin
administration and dose titration, and exercise [6].
Although epidemiological data on patients with type 1
diabetes in Brazil are still scarce, incidence seems to be
increasing (incidence rate of 18.49/100,000) [8]. Indeed,
the direct medical costs of type 1 diabetes in Brazil are
about US$1319.15 per patient for our national health
service, not including the expenditure on chronic dia-
betic complications [9]. This aspect is relevant since the
majority of our patients are at high risk of developing
chronic diabetic complications. A survey conducted in
573 patients with type 1 diabetes in the south of Brazil
demonstrated a high prevalence of diabetic retinopathy
(43.3 %) and diabetic kidney disease (34.5 %) [10].
Despite advances in therapeutics, poor glycemic control
is still a reality in many type 1 diabetic patients [11, 12]. Ac-
cordingly, up to 78 % of Brazilian patients with type 1 dia-
betes do not attain glycemic targets. Table 1 shows mean
HbA1c and the percentage of patients with type 1 diabetes
who attain glycemic targets in different Brazilians centers.
Poor compliance with diabetes treatment is probably
an important determinant of poor glycemic control ob-
served in patients with type 1 diabetes. As adherence to
treatment increases, HbA1c decreases as demonstrated
by a meta-analysis of 21 cross-sectional studies including
2492 youth with type 1 diabetes [13]. Multicomponent
adherence or self-management promoting interventions
seems to be more potent than single ones, although with
a borderline beneficial effect on HbA1c [14]. Many fac-
tors have been associated with adherence to diabetes
treatment and glycemic control such as economic status
[15], access to diabetes care [16] and devices to self-
monitor blood glucose [17], family support [18], social
and peer pressures [19], interactions with their health-
care providers [16], presence of depression [18], and
Table 1 Mean glycated hemoglobin (HbA1c) and percentage of patients with type 1 diabetes who are on glycemic target in
Brazilian centers
Author Number Region of Brazil HbA1c (%) Percentage of
patients on
glycemic
target*
(mean ± SD)
Rodrigues et al. 2010 [10]a 573 South 9.0 ± 3.9 22.0 %
Mendes et al. 2010 [49]b 979 South, Southeast, Northeast, Middle-west - 7.0 %
Gomes et al. 2012 [50]c 3591 South, Southeast, North/Northeast, Middle-west 9.1 ± 2.3 to 9.4 ± 2.6 12.2 to 21.4 %
Gomes et al. 2012 [51]d 1774 South, Southeast, North/Northeast, Middle-west 9.1 ± 2.2 11.6 %
Viana et al. 2013 [52]e 1026 South, Southeast, North/Northeast, Middle-west 9.3 ± 2.3 13.0 %
*Glycemic targets: a, b, eHbA1c <7.0 %; c, dHbA1c <7 % – adults, HbA1c <7.5 % – 13 to 19 years, HbA1c < 8 % – 6 to 12 years, HbA1c >7.5 % and HbA1c <8.5 %
– < 6 years
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transition to adolescence [18–20]. In this sense, non-
pharmacological strategies for improving adherence to
diabetes care, resulting in improved glycemic control,
have been studied: psychological [21–29], telecare or
Internet-based [30–35], educational [26, 36–38], and
psychoeducational [39] interventions. Although other
meta-analyses [30, 40], have already examined the effect
of non-pharmacological interventions on compliance
with diabetes treatment, the efficacy of such strategies is
still uncertain.
Considering the poor glycemic control, the high preva-
lence of chronic diabetic complications, and the increasing
worldwide prevalence of type 1 diabetes among children
and adolescents [41, 42] it is crucial to identify factors that
improve adherence to diabetes treatment. The aim of this
study was to evaluate the efficacy of psychological, tele-
care, and educational interventions to improve treatment
compliance among patients with type 1 diabetes. Compli-
ance was assessed indirectly using reduction of HbA1c as
the principal outcome measure.
Methods
This systematic review was carried out using a protocol
constructed according to the Cochrane Handbook recom-
mendations [43] and reported in accordance with Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) statement [44] (Additional file 1).
Data sources and searches
We searched databases from Medline, Embase, Cochrane,
and Scopus to identify randomized controlled clinical trials
(RCTs) that reported non-pharmacological interventions to
improve adherence to diabetes treatment in patients with
type 1 diabetes up to April 2015. The initial search com-
prised the following medical subject headings: “Diabetes
Mellitus, Type 1” [Mesh], “Patient Compliance” [Mesh], or
Adherence, “Hemoglobin A, Glycated” [Mesh], and related
entry terms associated with a high sensitivity strategy for
the search of RCTs available at http://www.sign.ac.uk/meth-
odology/filters.html#random (see Appendix section). All
potentially eligible studies were considered for review, lim-
ited to the English, Spanish, or Portuguese language. A
manual search was also performed in the reference lists of
included articles.
Study selection
We included RCTs that reported changes in the HbA1c
as differences between final and baseline interventions
in RCTs. We excluded studies if they were not random-
ized, were crossover trials, included patients with type 1
and type 2 diabetes being analyzed together, included
pregnant patients, or had no information about HbA1c.
Data extraction and quality assessment
All citations retrieved from electronic databases were
imported to the EndNote Program. Two reviewers
(MJA, LVV) independently analyzed the titles and ab-
stracts of every paper retrieved from the literature search
to identify potentially eligible studies. All studies that
did not meet the inclusion criteria were excluded. The
full text of the remaining papers was obtained for fur-
ther examination. The same two reviewers using a stan-
dardized data extraction form independently extracted
data of the included studies. Extracted data included first
author’s name, year of publication, number of partici-
pants, details of the study design (i.e., randomization
method), trial duration, and patient characteristics (age,
gender, ethnicity, diabetes duration). Studies were divided
into four categories according to the type of intervention:
psychology, telecare, education, and psychoeducation.
Briefly, telecare intervention was defined as teleconsulta-
tion, tele-expertise, or telemonitoring [45]. Behavioral,
multisystemic, and motivational approaches were
considered a psychological intervention and any struc-
tured educational program as an educational interven-
tion. Psychoeducation intervention was defined when
psychological and educational tools were implemented
at the same intervention.
Methodological quality assessment of included RCTs
was independently assessed by the same two reviewers
(MJA, LVV). We used the Cochrane Collaboration tool
for assessing risk of bias of every included study. Accord-
ing to the Cochrane Collaboration, biases were classified
into six domains: selection, performance, detection, attri-
tion, reporting, and other [43, 46]. The risk of bias for
each domain was classified as high, low, or unclear.
Data synthesis and analysis
Descriptive data from the systematic review were pre-
sented as mean and/or range, when available. We ana-
lyzed HbA1c (%) as a continuous variable and reported
HbA1c changes as absolute differences between arith-
metic means at baseline and end-of-study and mean dif-
ferences (MD) were used in the analyses (fixed models).
The heterogeneity between the studies was evaluated
by Cochran’s chi-squared test (Q test) and a P value for
trend ≤0.10 was considered statistically significant. The
I2 test was also performed to evaluate the magnitude of
heterogeneity [47] and statistical heterogeneity was con-
sidered in the presence of I2 values >75 %. Subgroup
analyses were performed including only RCTs conducted
with children and teenagers.
All statistical analyses will be performed using Stata
11.0 software (StataCorp, College Station, TX, USA). Sig-
nificance was set at P <0.05 and 95 % confidence inter-
vals are quoted throughout.
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Results
Literature search
We identified 191 studies in database searches. Of these,
67 studies were excluded due to duplication. Another 67
articles were excluded based on title or abstract: 24 studies
were not performed in patients with type 1 diabetes; 31
studies had no information about treatment compliance;
seven studies did not report HbA1c; and five studies had a
non-randomized design. Then we evaluated the full texts
of 57 articles. Two additional papers identified in the ref-
erences of the revised articles were also fully evaluated.
Hence, from a total of 57 studies, 40 were excluded and
19 trials, which fulfilled all selection criteria, were in-
cluded in the current systematic review (Fig. 1).
Study characteristics
This systematic review included a total of 1782 patients
with type 1 diabetes aged 18 years (12 to 46), 49.4 %
males, 71.6 % of white ethnicity, and with a mean duration
of diabetes of 9.3 years (3.7 to 23). Baseline mean HbA1c
in intervention groups ranged from 8.2 % to 11.4 % and
from 8.2 % to 11.3 % in the control groups. Trial duration
varied from 2 to 24 months.
RCT characteristics according to each intervention cat-
egory are described in Table 2. Table 3 depicts risk of bias
in each individual RCT evaluating interventions to improve
compliance with lower HbA1c in patients with type 1 dia-
betes. Most of the quality domains of studies included in
these meta-analyses revealed a low or uncertain bias risk.
The data available from the reviewed RCTs allowed us to
perform meta-analyses of psychological, educational, and
telecare interventions. Only one trial evaluated combined
psychological and educational interventions (psychoeduca-
tion category). Therefore, this trial was included only in
the systematic review.
Psychological interventions
Systematic review of psychological interventions included
six RCTs [21–29] and 783 patients aged 16.4 years (8 to
47), most of them, but one [26] conducted in children and
adolescents. Patients were mostly white (75 %) and about
half of them were male with a mean diabetes duration of 7
years (4 to 24) years. Baseline HbA1c in intervention was
9.2 % (8.7 to 11.4 %) and 9.1 % (8.2 to 11.3 %) in the con-
trol group. Duration of intervention was 10.2 months (11
weeks to 24 months). The psychological approaches used
in RCTs are described in Table 1.
Nine studies were initially considered for inclusion in
the psychological interventions meta-analysis [21–24, 26,
28]. However, the four studies conducted by Ellis et al.
[21–24] presented complementary data and the same pa-
tients were evaluated. Then, we included data of only one
study to avoid including the same individuals inappropri-
ately twice in the pooled estimate. Therefore, four studies
which presented baseline and end-of-study data were in-
cluded in this meta-analysis.
The interventions promoted a significant reduction in
HbA1c (MD −0.310 %; 95 % CI, −0.599, −0.021; P = 0.035).
Fig. 1 Flow diagram of literature search to identify randomized clinical trials evaluating interventions to improve compliance with lower glycated
hemoglobin (HbA1c) values in patients with type 1 diabetes
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Table 2 Characteristics of included randomized clinical trials evaluating interventions to improve compliance with lower glycated hemoglobin (HbA1c) in patients with type 1
diabetes according to intervention categories
Study Sample Intervention and Control groups HbA1c changes/comments
Psychological
category
Ellis, 2005, 2007 [21–
24] (4 published
complementary
reports)
n = 127 Age = 13.3 years Diabetes
duration = 5.3 years Male = 62 (48 %)
White = 33 (26 %)
Intervention Multisystemic therapy: intensive and home- and
community-based, originally designed for youths with antisocial
behavior. Duration of intervention: 5.7 months Control Standard
medical care: quarterly visit of multidisciplinary team
Intervention Baseline = 11.4 ± 2.2 % End-of-study = 10.8 ±
2.6 % Control Baseline = 11.3 ± 2.3 % End-of-study = 11.3
± 2.3 % Significant reduction of HbA1c only in the interven-
tion group Compliance evaluation of the psychological inter-
vention: semi structured interview
Nansel, 2007 [25] n = 81 Age =13.6 years Diabetes
duration = 7.6 years Male = 36 (44 %)
White = 69 (85 %)
Intervention “Diabetes Personal Trainer”: approach guided by
principles of motivational interviewing, applied behavior analysis,
and problem solving. Duration of intervention: 2 months Control
Education plus standard diabetes care
No significant reduction in HbA1c in intervention and
control groups, but absolute values were not described
Compliance evaluation of the psychological intervention:
modified version of Diabetes –Management Profile
Weinger, 2011 [26] n = 110a Age = 46.6 years Diabetes
duration = 23.7 years Male = 48 (48 %)
White = 105 (96 %)
Intervention Structured behavioral intervention: five 2-hour ses-
sions. Duration of intervention: 6 weeks Control Individual ap-
pointments with diabetes nurse and dietitian educators
Intervention Baseline = 9.0 ± 1.9 % End-of-study = 8.7 ± 1.2
% Control Baseline = 8.7 ± 0.6 % End-of-study = 8.5 ± 1.1
% Changes of HbA1c were described but statistical analysis
was not reportedCompliance evaluation of the psycho-
logical intervention: frequency of diabetes self-care, 3-day
pedometer readings, 24-hour diet recalls, average number
of glucose checks.
Nansel, 2012 [27] n = 390 Age = 12.5 years Diabetes
duration = 4.8 years Male = 191 (49 %)
White = 273 (70 %)
Intervention Clinic-integrated behavioral: designed to improve family
diabetes management (WE-CAN manage diabetes). Duration of
intervention: 24 months Control Standard medical care
Significant reduction of HbA1c occurred only in the
intervention group, but absolute values were not described
Compliance evaluation of the psychological intervention:
semi structured interview
Mulvaney, 2010 [28] n = 72 Age =15.1 years Diabetes
duration: 6.3 years Male = 40 (56 %)
White = 66 (92 %)
Intervention Learning, social-cognitive and self-determination
management by website support. Duration of intervention: 11
weeks. Control Usual care
Intervention Baseline = 9.1 ± 1.9 % End-of –study = 9.1 ±
1.8 % Control Baseline = 8.2 ± 1.2 % End-of-study = 8.5 ±
1.3 % No significant reduction in HbA1c in intervention and
control groups Compliance evaluation of the psycho-
logical intervention: The Diabetes Rating Scale
Franklin, 2006 [29] n = 61 Age = 13.5 years Diabetes
duration = 4.1 years Male = 34 (56 %)
White = 59 (97 %) Results referred only
to patients on conventional insulin arm
Intervention “Sweet talk”: motivational support network to deliver
behavioral intervention through mobile. Duration of intervention:
unclear Control Usual care
Intervention Baseline = 9.8 % End-of-study = 10.1 ± 1.7 %
Control Baseline = 10.1 % End-of-study = 10.3 ± 1.7 % No
significant reduction in HbA1c in intervention and control
groups Compliance evaluation of the psychological
intervention: self-report adherence
Telecare category
Montori, 2004 [30] n = 31
Age = 43 years Diabetes duration = 17 years
Male = 10 (32 %) White = no information
Intervention Monitoring blood glucose four times/day and
transmitting recorded data twice a week with feedback from a
nurse supervised by an endocrinologist 24 hours after the
transmission. Duration of intervention: 6 months Control Same
monitoring requested but without feedback
Intervention Baseline = 9.3 ± 1.3 % End-of-study = 7.8 ± 1.3
% Control Baseline = 8.8 ± 1.2 % End-of-study = 8.2 ± 1.2
% Significant reduction of HbA1c only in the interven-
tion group Compliance evaluation of the telecare inter-
vention: SMBG and insulin use
Lawson, 2005 [31] n = 46 Age = 15.2 years Diabetes
duration = 6.5 years Male = 26 (56 %)
White = no information
Intervention Weekly standardized telephone contact with a diabetic
nurse specialist to discuss blood sugar over the last week and
performing insulin adjustments using standard rules and algorithms.
Intervention Baseline = 10 ± 1.3 % End-of-study = 9.4 ± 1.4
% Control Baseline = 9.7 ± 0 .6 % End-of-study = 9.2 ± 1.4
% No significant reduction of HbA1c in intervention and
control groups Compliance evaluation of the telecare
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Table 2 Characteristics of included randomized clinical trials evaluating interventions to improve compliance with lower glycated hemoglobin (HbA1c) in patients with type 1
diabetes according to intervention categories (Continued)
Duration of intervention: 6 months Control Standard care with
quarterly visit with a nurse and an endocrinologist
intervention: general adherence with diabetes manage-
ment (blood glucose testing, insulin schedule, food plan, glu-
cose goals, exercise)
Farmer, 2005 [32] n = 93 Age = 23.8 years Diabetes
duration = 12.1 years Male = 55
(59 %) White = no information
Intervention Clinical advice and structured specialized nurse
counseling in response to real-time blood glucose test results.
Duration of intervention: 9 months Control Data transmission without
feedback
Intervention Baseline = 9.2 ± 1.1 % End-of-study = 8.6 ± 1.4
% Control Baseline = 9.3 ± 1.5 % End-of-study = 8.9 ± 1.4 %
Significant reduction of HbA1c in intervention and control
groups, without difference between them Compliance
evaluation of the telecare intervention: SMBG
Landau, 2011 [33] n = 70 Age = 15 years Diabetes
duration = 5.7 years Male = 32 (46 %)
White = no information
Intervention Weekly upload of the self-monitoring blood glucose and
feedback from study coordinator. Parents were contacted if any change
in the treatment was necessary. Duration of intervention: 6 months Con-
trol Data upload without study coordinator feedback
Intervention Baseline = 8.5 ± 1.4 % End-of-study = 8.5 ± 1.4
Control Baseline = 8.2 ± 1.1 % End-of-study = 8.4 ± 1.1 %
No significant reduction of HbA1c in intervention and
control groups Compliance evaluation of the telecare
intervention: SMBG
Gay, 2006 [34] n = 100 Age = 13.3 years Diabetes
duration = 6.2 years Male = 32 (61 %)
White = no information
Intervention Twice a month children went to a selected pharmacy
to download data stored in their glucometer. Data was transmitted
to a pediatric diabetologist and within 5 days feedback was
provided. Duration of intervention: 6 months Control Usual follow-
up
Intervention Baseline = 9.2 ± 1.1 % End-of-study = 9.1 ± 1.5
% Control Baseline = 9.2 ± 1 % End-of-study = 9.3 ± 1.2 %
No significant reduction of HbA1c in intervention and con-
trol groups. There were problems with software installation
Compliance evaluation of the telecare intervention: SMBG
and insulin adjustments
Esmatjes, 2014 [35] n = 154 Age = 31.7 years Diabetes
duration = 17.7 years Male = 69 (44.9 %)
White = no information
Intervention Five telematic visits, and management of the Medical
Guard Diabetes (MGD) system (Pulso Ediciones, Barcelona, Spain)
with data reports once a month and responses of diabetes team in
the following 3 days with recommendations on treatment
adjustments. Duration of intervention: 6 months Control All visits
were in hospital and data were obtained on site during the visits
Intervention Baseline = 9.3 ± 1.5 % End-of-study = 8.7 ± 1.5
% Control Baseline = 9.2 ± 0.9 % End-of-study = 8.6 ± 0.9
% No significant reduction of HbA1c between intervention
and control groups Compliance evaluation of the telecare
intervention: self-care treatment adherence
Educational category
Cook, 2002 [36] n = 53 Age = 14.6 years Diabetes
duration = no information Male = 26 (49 %)
White = 45 (85 %)
Intervention Small group education to teach adolescents to became
more responsible with day-to-day diabetes care (Choices Program).
Duration of intervention: 6 weeks Control Usual care
Intervention Baseline = 8.9 ± 1.3 % End-of-study = 8.3 ± 1.4
% Control Baseline = 9.3 ± 2 .1 % End-of-study = 9.0 ±
1.9 % No significant reduction of HbA1c in interven-
tion and control groups at 6 months Compliance
evaluation of the educational intervention: SMBG and
Diabetes Problem Solving Questionnaire
Howe, 2005 [37] n = 49 Age = 12.8 years Diabetes
duration = no information Male = 28 (57 %)
White = 27 (55 %)
Intervention Single educational intervention to provide families with
basic diabetes management skills. Duration of intervention: one
session Control Standard care with quarterly visit with a nurse
practitioner and an endocrinologist
Intervention Baseline = 10.1 ± 1.2 % End-of-study = 9.7 ±
1.9 % Control Baseline = 10.2 ± 1.4 % End-of-study = 9.9 ±
1.6 % No significant reduction of HbA1c in intervention and
control groups Compliance evaluation of the educational inter-
vention: Adherence Clinician Checklist
Howe, 2005 [37] n = 54 Age = 12.1 years Diabetes
duration: no information Male = 29 (54 %)
White = 28 (52 %)
Intervention Single educational intervention to provide families with
basic diabetes management skills plus weekly phone calls for 3
months and then bimonthly. Study coordinator followed a standard
protocol on the phone talking about problem-solving skills related
to diabetes care. Duration of intervention: 6 months Control Stand-
ard care with quarterly visit with nurse practitioner and an
endocrinologist
Intervention Baseline = 10 ± 1.4 % End-of-study = 9.5 ±
1.7 % Control Baseline = 10.2 ± 1.4 % End-of-study =
9.9 ± 1.6 % No significant reduction of HbA1c in inter-
vention and control groups Adherence / Compliance evalu-
ation: Adherence Clinician Checklist.
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Table 2 Characteristics of included randomized clinical trials evaluating interventions to improve compliance with lower glycated hemoglobin (HbA1c) in patients with type 1
diabetes according to intervention categories (Continued)
Weinger, 2011 [26] n = 110b Age = 46.6 years Diabetes
duration = 23.7 years Male = 48 (48 %)
White = 105 (96 %)
Intervention Five 2-hour sessions of manual-based group diabetes
education Duration of intervention: 6 weeks Control Individual
appointments with diabetes nurse and dietitian educators
Results of HbA1c were described together for patients with
type 1 and type 2 diabetes Compliance evaluation of the
educational intervention: frequency of diabetes self-care, 3-
day pedometer readings, 24-hour diet recalls, average number
of glucose checks
Nunn, 2006 [38] n = 123 Age = 11.6 years Diabetes
duration = 3.7 years Male = 69 (56 %)
White = no information
Intervention Bimonthly phone calls from a diabetes educator
covering the three main topics insulin use, carbohydrate intake and
blood glucose values with a written educational program. Duration
of intervention: 7 months Control Usual care
Intervention Baseline = 8.2 ± 1.1 % End-of-study = 8.9 ± 1.3
% Control Baseline = 8.3 ± 1.01 % End-of-study = 8.8 ± 1.1
% No significant reduction of HbA1c in intervention and
control groups at 6 months Compliance evaluation of
the educational intervention: SBGM, limited screen
time, exercise practice, rotation of injection sites, warrant
bracelets worn
Psychoeducation
category
Katz, 2014 [39] n = 153 Diabetes duration = 12.8 years
Male = 67 (44 %%) White = no information
Intervention 1 Psychoeducation was performed as 30-minute
quarterly sessions with the patient, parent or guardian, and a
non-medical care ambassador. Material was related to: family manage-
ment of diabetes, problem-solving exercises and role-playing realistic ex-
pectations, glucose self-monitoring, avoidance of weight gain, and
hypoglycemia. Duration of intervention: 2 years Intervention 2 Partici-
pants received monthly outreach by the care ambassador via
phone or email, in addition to the quarterly diabetes care and ambas-
sador care coordination. Duration of intervention: 2 years Intervention 3
Standard care including basic care coordination by the care ambassa-
dor (to assist in scheduling quarterly clinic visits)
Intervention 1 Baseline = 8.3 ± 1.4 % End-of-study = 8.6 ±
1.0 % Intervention 2 Baseline = 8.5 ± 1.4 % End-of-study =
8.8 ± 1.0 % Intervention 3 Baseline = 8.5 ± 1.4 % End-of-
study = 8.6 ± 1.0 % No significant reduction of HbA1c in
intervention and control groups
at 2 years Compliance evaluation of the educational
intervention: Diabetes Family Responsibility Questionnaire
aResults referred to two out of three study arms: behavior versus individual care; HbA1c results were from 73 patients
bResults referred to two out of three study arms: educational versus individual care; HbA1c results were from 73 patients
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No heterogeneity was found in this analysis (I2 0 %;
P = 0.615).
Telecare interventions
Systematic review of telecare interventions evaluated six
RCTs [30–35], including 494 patients with mean age
25.8 (13 to 43 years). No information about ethnicity
was provided and about half of patients were males. Dia-
betes duration was 11.43 years (5.7–17.2). The length
of most studies was 6 months and only one lasted for
9 months. The description of telecare interventions
used in RCTs is shown in Table 1.
All six RCTs were included in the meta-analysis of
telecare intervention. The HbA1c of patients submit-
ted to telecare interventions was not reduced during
trials (MD −0.124 %; 95 % CI, −0.268, 0.020; P =
0.090) (Fig. 2). No heterogeneity was found in this
analysis (I2 35.8 %; P = 0.168).
Fig. 2 Forest plots of interventions to improve compliance with lower glycated hemoglobin (HbA1c) in patients with type 1 diabetes: a
Psychological. b Telecare. c Education categories
Table 3 Meta-analysis: risk of bias in individual randomized clinical trials evaluating interventions to improve compliance to lower
glycated hemoglobin (HbA1c) in patients with type 1 diabetes according to intervention category
Selection bias Performance bias Detection bias Attrition bias Reporting bias
Random sequence
generation
Allocation
concealment
Blinding of participant
and personnel
Blinding of outcome
assessment
Incomplete
outcome data
Selective
reporting
Psychology category
Ellis, 2005 –2007b low low low low uncertain low
Nansel, 2007 low low low low high uncertain
Weinger, 2011a low low low low uncertain low
Nansel, 2011 low low high uncertain high low
Mulvaney, 2010 low low uncertain uncertain uncertain uncertain
Franklin, 2006 low low low uncertain uncertain low
Telecare category
Montori, 2004 low low low uncertain uncertain low
Lawson, 2005 low low low low uncertain low
Farmer, 2005 low low low low uncertain low
Landau, 2011 low low low low uncertain low
Gay, 2006 low low low low uncertain low
Esmatjes, 2014 low low uncertain uncertain uncertain low
Education category
Cook, 2002 uncertain uncertain low uncertain uncertain low
Howe, 2005 uncertain uncertain uncertain low uncertain low
Weinger, 2011b low low low low uncertain low
Nunn, 2006 low low low low uncertain low
aThe same study had three arms evaluated as: psychology versus individual care and education versus individual care interventions
bFour published complementary reports
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Educational interventions
Systematic review of educational interventions included
four RCTs [26, 36–38] and 352 patients 19.6 years old
(12 to 46). Trials were conducted mainly in children and
adolescents. Patients were mostly white (65 %) and
about half of them were male. Mean diabetes duration
was described in only two studies. The duration of inter-
vention varied from a single session to 12 months. The
educational interventions used in RCTs are described in
Table 1.
In the meta-analysis of included RCTs, five interven-
tions were evaluated in four trials. No change in HbA1c
was observed with educational approaches (MD −0.001 %;
95 % CI, −0.202, 0.200; P = 0.990) (Fig. 2). No heterogen-
eity was found in this analysis (I2 0 %; P = 0.426).
Psychoeducation intervention
One trial combined psychological and educational inter-
vention [39] including 153 patients with type 1 diabetes
(44 % males, age 12.8 years) and evaluated three inter-
vention arms. The psychoeducation arm consisted in 30-
minute quarterly sessions. Psychoeducational material
was related to family management of diabetes, avoiding
perfectionism and setting realistic goals (psychological
intervention), and glucose self-monitoring, weight gain,
and hypoglycemia (educational intervention). Psychoe-
ducational intervention was compared to usual care or
usual care plus monthly phone calls or email reinforce-
ments. Care from a non-medical ambassador occurred
in all study arms. There was no difference in HbA1c
among groups at 2 years.
Subgroup analyses
Twelve of the 18 meta-analyzed trials were conducted
only in children and adolescents. We re-ran analyses
maintaining only these 12 RCTs [21–24, 28, 29, 33–37].
Results of these meta-analyses are described in Table 4.
No intervention (psychology, telecare, education) was
able to reduce HbA1c in this age specific population. No
heterogeneity was found in any meta-analysis.
Discussion
This was a systematic review of interventions aiming to re-
duce HbA1c in patients with type 1 diabetes by improving
compliance with therapy. The review considered 1782 indi-
viduals from 19 RCTs. We were able to perform three
meta-analyses according to the type of interventions: psych-
ology, telecare, and education. Psychological interventions
were associated with HbA1c reduction (MD −0.310; 95 %
CI, −0.599 to −0.0210, P = 0.035) but not meta-analyses of
telecare (MD −0.124 %; 95 % CI, −0.268, 0.020; P = 0.090)
or educational (MD −0.001; 95 % CI, −0.202, 0.200; P =
0.990) interventions.
Tight glycemic control is difficult to obtain in type 1
diabetic patients and any intervention that reduces HbA1c
is extremely helpful in controlling their diabetes. We iden-
tified two other systematic reviews on adherence in the
medical literature [13, 14]. One of them analyzed cross-
sectional studies [13]. The other study evaluated adher-
ence or self-management promoting strategies. However,
the authors performed a meta-analysis including all differ-
ent categories of intervention together and showed no im-
provement in glycemic control [14]. We believe that
stratifying intervention categories (such as psychology,
education, telecare), as we did in the current study, is a
more adequate statistical approach. In addition, it is im-
portant to emphasize that our literature search method
was quite unique: we performed an open search for RCTs
that improved patient compliance instead of searching for
specific interventions. This strategy could explain the dif-
ferences between our results and the previous reviews.
We also excluded crossover trials because it is hard to per-
form an adequate washout when dealing with subjective
interventions.
A systemic review of psychological and educational in-
terventions in adolescents with type 1 diabetes [40]
seemed to reduce HbA1c for both interventions but the
confidence interval for HbA1c changes was quite large.
Furthermore, this review was not projected to evaluate
whether the studied interventions were associated with
patients’ compliance with the diabetes treatment. Re-
garding telecare intervention, a meta-analysis conducted
in patients with type 1 diabetes did not reduce HbA1c
[30], similar to our results. However, that study was not
aimed to reduced HbA1c [30], and once again this study
was not designed to evaluate compliance.
Most children and teenagers with type 1 diabetes do
not meet traditional glycemic control targets [11] and
Table 4 Subgroup meta-analyses: changes in glycated hemoglobin (HbA1c) (%) in randomized clinical trials evaluating interventions
to improve compliance with lower HbA1c in children and teenagers with type 1 diabetes
Type of intervention Number
of
studies
Number
of
patients
MD 95 % CI P
HbA1c
Psychological [21–24, 28, 29] 3 239 -0.34% -0.72 to 0.035 % 0.083
Telecare [32–35] 3 554 -0.18% -0.40 to 0.03 % 0.098
Educational [36–38] 4 631 0.046 -0.80 to 0.272 0.689
MD mean differences
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recently the American Diabetes Association reduced
HbA1c goals for youth [12]. Interestingly, in our data
search we found that most studies were performed in
children and adolescents. Therefore, we decided to per-
form a subgroup analysis including only these patients.
Indeed, the management of children and teenagers with
diabetes usually has peculiarities, including non-
pharmacological interventions (e.g., family involvement)
[18]. Unfortunately, we were not able to confirm benefits
of any studied intervention in this specific population
similar to those described by other authors [40]. Inclu-
sion of a greater number of studies in pediatric patients
could have shown improvement in glycemic control
since there is still a clear trend to lower HbA1c by psy-
chological intervention according to our subgroup
analysis.
A possible limitation of our systematic review could be
the small number of studies in each intervention cat-
egory. Since we performed complete-case analyses [48],
the missing data in some of reviewed trials precluded
their inclusion in our meta-analyses. In theory the
choice to use only studies that report baseline and final
values could lead to the possibility of selective reporting
[43]. Indeed, analyses based on changes from baseline
will be more efficient and powerful than comparisons of
final values [43], especially when analyzing HbA1c
values. The quality of included studies could represent a
weakness in our meta-analyses. Nevertheless, only the
study of Nansel et al. [27] included a psychological inter-
vention and there were two high domain biases: blinding
bias, which was not truly applicable to this type of inter-
vention, and incomplete data. All other studies included
revealed a low or uncertain bias risk. Contact with non-
responding authors remains a problem in performing
meta-analyses since we could not recover any missing
data after personal contact. It would be interesting to
compare all included trials through a network meta-
analysis. However, different strategies without a common
comparator prevented us from performing this analysis.
Conclusion
We performed this systematic review because there was
no clear information available regarding which kind of
intervention should be used to improve compliance with
general diabetes treatment aimed at lowering HbA1c
(improvement of glycemic control). Unfortunately, so far
we could only demonstrate psychological intervention as
the sole evidence-based recommendation; the number of
included studies was relatively low but their quality
allowed us to conclude that this tool can be useful in the
management of diabetic patients. In conclusion, we
demonstrated that in patients with type 1 diabetes psy-
chological interventions to improve patients’ compliance
with diabetes treatment did improve glycemic control.
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